Filing Details

Accession Number:
0001209191-16-137770
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-18 16:26:00
Reporting Period:
2016-08-17
Filing Date:
2016-08-18
Accepted Time:
2016-08-18 16:26:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197023 S Joshua Boger C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-17 6,500 $36.30 274,725 No 4 M Direct
Common Stock Disposition 2016-08-17 4,000 $99.36 270,725 No 4 S Direct
Common Stock Disposition 2016-08-17 2,500 $99.99 268,225 No 4 S Direct
Common Stock Disposition 2016-08-17 400 $100.03 80,300 No 4 S Indirect Common Stock Held In Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Common Stock Held In Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-08-17 6,500 $0.00 6,500 $36.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
138,000 2017-01-23 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,286 Indirect 401k
Footnotes
  1. Transaction made pursuant to the holder's company approved trading plan under Rule 10b5-1.
  2. The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $99.36 (range $98.87 to $99.84).
  4. Open market sales reported on this line occurred at a weighted average price of $99.99 (range $99.91 to $100.12).
  5. Open market sales reported on this line occurred at a weighted average price of $100.03 (range $100.00 to $100.08).
  6. Fully vested.